不同雾化吸入药物治疗老年慢性支气管炎的临床疗效观察

Clinical efficacy of different aerosol inhalation drugs in the treatment of chronic bronchitis in the elderly

目的:探讨不同雾化吸入药物治疗老年慢性支气管炎的效果。方法:收治老年慢性支气管炎患者54例,随机分为参照组和试验组,各27例。参照组给予布地奈德混悬液氧气雾化吸入治疗,试验组在此基础上联合沐舒坦雾化吸入。结果:试验组喘息缓解时间、咳嗽缓解时间、住院时间以及总有效率与参照组对比,差异有统计学意义(P<0.05)。结论:将不同雾化吸入药物应用在老年慢性支气管炎中均可获得显著效果,但是布地奈德混悬液氧气雾化吸入与沐舒坦雾化吸入联合治疗效果更显著。

Objective：To explore the effect of different inhalation drugs in the treatment of chronic bronchitis in the elderly.Methods：54 hospitalized elderly patients with chronic bronchitis were selected.They were randomly divided into the control group and the experimental group with 27 cases in each.The control group were given budesonide oxygen atomization inhalation treatment,while the experimental group combined Mucosolvan aerosol inhalation with budesonide oxygen atomization inhalation treatment.Results：There was a statistically significant difference in wheezing relief time,cough relief time,hospitalization time and total effective rate between the experimental group and the reference group（P0.05）.Conclusion：Different inhalation drug application can obtain significant effect in elderly patients with chronic bronchitis,but budesonide oxygen atomization inhalation combined with ambroxol aerosol inhalation has more significantly treatment effect.